title: Reduction of phagocyte adherence by nephritic sera: relation to complement activation.
abstract: Phagocytes isolated from either normal donors or from patients with poststreptococcal (P-SGN), lupus erythematosus (SLE-GN), or membranoproliferative (MPGN) glomerulonephritis showed normal adherence to glass (PAg) after incubation in normal human serum (NHS), but was reduced after incubation in patient serum. Low PAg was the consequence of incubation of normal phagocytes with the earliest available sera from all 22 P-SGN patients, 28 of 37 SLE-GN patients, 19 of 25 patients with MPGN type I, all 10 with types II and III, and all 5 with nephritis associated with chronic bacteremia. Low C3 and decreased PAg were related by regression analysis in sera from patients with P-SGN (P less than 0.001), SLE-GN (P less than 0.005), and MPGN (P less than 0.001) type I. In patients with P-SGN and one patient with nephritis associated with chronic bacteremia, complement levels and PAg returned to normal in parallel with clinical improvement. In vitro, PAg was reduced by NHS treated with either zymosan or bovine serum albumin (BSA)-anti-BSA complexes but neither BSA-anti-BSA complexes or zymosan, previously incubated in NHS, reduced PAg. PAg was normal in serum deficient in C4 or C5 unless treated with zymosan.
mesh_terms: D000328:Adult; D000936:Antigen-Antibody Complex / Q000032:analysis; D002448:Cell Adhesion; D002648:Child; D003166:Complement Activating Enzymes / Q000032:analysis; D003167:Complement Activation; D015922:Complement C1q; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D011415:Complement Factor B / Q000032:analysis; D005898:Glass; D005921:Glomerulonephritis / Q000097:blood*; D006801:Humans; D010586:Phagocytes / Q000166:cytology* / Q000276:immunology; D011414:Properdin / Q000032:analysis
chemical_list: D000936:Antigen-Antibody Complex; D003176:Complement C3; D003181:Complement C4; D011414:Properdin; D015922:Complement C1q; D003166:Complement Activating Enzymes; D011415:Complement Factor B